LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $99,000 | +3.1% | 10,757 | -28.6% | 0.00% | – |
| Q1 2019 | $96,000 | -34.7% | 15,063 | -3.7% | 0.00% | – |
| Q4 2018 | $147,000 | -83.2% | 15,637 | -64.1% | 0.00% | -100.0% |
| Q3 2018 | $877,000 | +76.5% | 43,546 | +155.4% | 0.00% | – |
| Q2 2018 | $497,000 | -2.0% | 17,047 | +0.1% | 0.00% | – |
| Q1 2018 | $507,000 | -6.3% | 17,037 | +1.1% | 0.00% | – |
| Q4 2017 | $541,000 | -43.3% | 16,855 | -38.5% | 0.00% | -100.0% |
| Q3 2017 | $954,000 | -0.2% | 27,425 | -14.6% | 0.00% | 0.0% |
| Q2 2017 | $956,000 | +144.5% | 32,100 | +145.4% | 0.00% | – |
| Q1 2017 | $391,000 | +41.2% | 13,083 | +12.2% | 0.00% | – |
| Q3 2016 | $277,000 | -47.1% | 11,659 | -64.4% | 0.00% | -100.0% |
| Q2 2016 | $524,000 | +52.3% | 32,741 | +156.4% | 0.00% | – |
| Q4 2015 | $344,000 | -74.0% | 12,768 | -73.1% | 0.00% | -100.0% |
| Q3 2015 | $1,321,000 | +563.8% | 47,530 | +157.8% | 0.00% | – |
| Q1 2014 | $199,000 | – | 18,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $110,713,000 | 17.54% |
| Consonance Capital Management LP | 2,079,311 | $66,912,000 | 6.04% |
| RTW INVESTMENTS, LP | 1,063,170 | $34,213,000 | 5.71% |
| Broadfin Capital, LLC | 1,029,866 | $33,141,000 | 5.42% |
| Perceptive Advisors | 3,388,611 | $109,046,000 | 3.62% |
| SECTORAL ASSET MANAGEMENT INC | 854,301 | $27,491,000 | 3.44% |
| Boxer Capital, LLC | 267,500 | $8,608,000 | 1.57% |
| Ghost Tree Capital, LLC | 200,000 | $6,436,000 | 1.51% |
| EMORY UNIVERSITY | 51,632 | $1,662,000 | 1.43% |
| Stanley-Laman Group, Ltd. | 168,653 | $5,427,000 | 1.17% |